Adoptive immunotherapy of cancer using CD4+ T cells
- 30 April 2009
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Immunology
- Vol. 21 (2), 200-208
- https://doi.org/10.1016/j.coi.2009.02.004
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Global Mapping of H3K4me3 and H3K27me3 Reveals Specificity and Plasticity in Lineage Fate Determination of Differentiating CD4+ T CellsImmunity, 2009
- Late Developmental Plasticity in the T Helper 17 LineageImmunity, 2009
- Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cellsEuropean Journal of Immunology, 2009
- The known unknowns of antigen processing and presentationNature Reviews Immunology, 2008
- Generation of T Follicular Helper Cells Is Mediated by Interleukin-21 but Independent of T Helper 1, 2, or 17 Cell LineagesImmunity, 2008
- Molecular Antagonism and Plasticity of Regulatory and Inflammatory T Cell ProgramsImmunity, 2008
- Development, cytokine profile and function of human interleukin 17–producing helper T cellsNature Immunology, 2007
- TH-17 cells in the circle of immunity and autoimmunityNature Immunology, 2007
- Increased intensity lymphodepletion and adoptive immunotherapy—how far can we go?Nature Clinical Practice Oncology, 2006
- Adoptive immunotherapy for cancer: building on successNature Reviews Immunology, 2006